# FLRish

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/flrish

- Industry: Healthcare
- Headquarters: Oakland, US
- Website: www.shopharborside.com
- Total disclosed funding: $31M
- Latest round: Series B (Nov 19, 2018)
- Investors on record: 4

## About

FLRish Inc. is a cannabis retailer specializing in high-quality products, including flower, concentrates, and edibles, aimed at meeting the needs of both recreational and medical users.FLRish Inc. was founded in 2006 and is headquartered in Oakland, US. The company focuses on retailing cannabis products cultivated from its own farms on the West Coast. It has successfully completed 3 deals, with the most recent deal occurring on May 17, 2019, when it raised USD 14.62 mn in funding from various investors. The company does not have publicly known subsidiaries or a parent company.Harborside offers a comprehensive range of cannabis products, including award-winning flower, concentrates, edibles, and other related items. Its retail locations provide high-quality products tailored to both new and experienced cannabis users in major urban centers across California, including San Francisco, San Jose, and Oakland, as well as Marin County and the Bay Area. Customer engagement is enhanced through consultations with trained cannabis experts.Harborside generates revenue through direct-to-consumer sales, allowing customers to purchase products in-store or online for pickup or delivery. The pricing structure is designed to appeal to a wide audience, offering discounts such as 40% off for club members and various limited-time sales. The firm operates under multiple licenses, ensuring compliance with state regulations while expanding its market presence.FLRish Inc. plans to leverage its recent funding of USD 14.62 mn raised in May 2019 to support product development and market expansion. The company aims to design and launch new cannabis products tailored for a broader audience. Additionally, FLRish intends to penetrate new geographic markets, focusing on regions with high demand for cannabis products, although specific markets and timelines for this expansion have not been disclosed.

## Funding rounds

- Series B, Nov 19, 2018, $26M — Salveo Capital
- Series A, May 1, 2018, $5M — Quinsam Capital Corporation, Entourage Effect Capital, Murray Field & Company

## Investors

- Quinsam Capital Corporation — Series A
- Entourage Effect Capital (https://capitalatlas.ai/funds/entourage-effect-capital) — Series A
- Murray Field & Company — Series A
- Salveo Capital (https://capitalatlas.ai/funds/salveo-capital) — Series B